Related Experiment Video
Updated: Feb 7, 2026
07:37
Assessment and Communication for People with Disorders of Consciousness
Published on: August 1, 2017
9.6K
Why do people die from pulmonary sarcoidosis?
Vasileios Kouranos1, Athol Wells1, Simon Walsh2
1Interstitial Lung Disease Unit, Royal Brompton Hospital.
Current Opinion in Pulmonary Medicine
|July 14, 2018
Summary
Identifying patients with pulmonary sarcoidosis at risk of severe fibrotic lung disease is challenging. Integrating clinical, pathological, and radiological features may help predict disease progression and mortality.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Immunology
Background:
- Sarcoidosis exhibits significant variability in presentation, evolution, and outcomes, complicating risk stratification.
- While many patients experience spontaneous resolution, 20-30% develop chronic or progressive lung disease, leading to morbidity and mortality.
- Current tools lack the ability to reliably predict which pulmonary sarcoidosis patients will progress to fibrosis.
Purpose of the Study:
- To review the utility of integrating clinical, pathological, and radiological features for risk stratification in pulmonary sarcoidosis.
- To identify determinants of mortality in patients with pulmonary sarcoidosis.
- To define advanced pulmonary sarcoidosis.
Main Methods:
- Literature review focusing on studies integrating clinical, pathological, and radiological data.
- Analysis of factors contributing to disease progression, morbidity, and mortality in pulmonary sarcoidosis.
- Examination of imaging's role in differentiating reversible from irreversible disease and assessing parenchymal damage.
Main Results:
- No reliable predictive tools currently exist for identifying patients who will develop fibrosis.
- Demographic factors like age, sex, and race show conflicting evidence regarding their predictive value.
- Imaging, symptoms, and lung function tests are key determinants, with changes over time being crucial.
Conclusions:
- A comprehensive approach integrating diverse patient data is needed for effective risk stratification in pulmonary sarcoidosis.
- Further research is required to develop reliable methods for predicting fibrotic progression and mortality.
- Understanding determinants of mortality is crucial for managing advanced pulmonary sarcoidosis.
Related Concept Videos
01:21Kubler Ross's Stages of Dying
1.3K
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
1.3K
01:29Pulmonary Tuberculosis I
991
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
991
01:28Pulmonary Tuberculosis II
1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
01:28Pulmonary Tuberculosis V
630
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
630
01:17Other Pulmonary Disorders
1.7K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.7K
01:19Overview of Pulmonary Circulation
3.2K
The pulmonary circulation is a vital system in our body that acts as a bridge between the respiratory and cardiovascular systems. It serves as a transport network for deoxygenated blood from the heart to the lungs and then returns oxygen-rich blood back to the heart.
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
3.2K